According to a new deal, two Indian pharmaceutical companies - Cipla and Ranbaxy Laboratories - have agreed to supply 19 different antiretroviral formulations for prices about 45 percent less than the lowest current rates for such drugs in developing countries.
One of the drugs the two companies make is described as a "new child-friendly product" and will cost less than $60 per year per child, the former president announced.
BBC quotes the statement as saying that the cheap drugs will be available in 62 developing countries in Africa, Asia, Latin American and the Caribbean.
The Clinton Foundation also announced that the international drug-buying facility, Unitaid, set up by France, Brazil, Chile, Norway and the UK, is subsidizing the program by $35 million.
"Though the world has made progress in expanding HIV/AIDS treatment to adults, children have been left behind. Only one in 10 children who needs treatment is getting it," BBC quotes Clinton as saying.
The main aim of this program is to see an increase in the number of children on treatment in India from less than 2,000 in September to 10,000 by the end of March.
It aims to achieve so by the easy availability of pediatrics care at all centers treating adults, the foundation's statement says.
According to statistics by the United Nations, over five million Indians are infected with HIV - more than in any other country in the world.
